COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES

GAL-289-PCT 37 ABSTRACT The present invention relates to the use of the compound according to Formula I in the prophylaxis and/or treatment of fibrotic diseases, more particularly idiopathic pulmonary fibrosis. La présente invention concerne l'utilisation du composé selon la formule I dans la p...

Full description

Saved in:
Bibliographic Details
Main Authors VAN DE STEEN, Olivier, VAN DER AAR, Elisabeth
Format Patent
LanguageEnglish
French
Published 14.02.2019
Subjects
CHEMISTRY
DIAGNOSIS
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SURGERY
Online AccessGet full text

Cover

More Information
Summary:GAL-289-PCT 37 ABSTRACT The present invention relates to the use of the compound according to Formula I in the prophylaxis and/or treatment of fibrotic diseases, more particularly idiopathic pulmonary fibrosis. La présente invention concerne l'utilisation du composé selon la formule I dans la prophylaxie et/ou le traitement de maladies fibrotiques, plus particulièrement de la fibrose pulmonaire idiopathique.
Bibliography:Application Number: WO2018EP71487